3 ms·
The Ridgeback founders were on CNBC this morning in a very encouraging interview. A few takeaways: 1. They are testing now as a prophylactic and anticipate pos
by tiahura 5y ago
The Ridgeback founders were on CNBC this morning in a very encouraging interview. A few takeaways: 1. They are testing now as a prophylactic and anticipate positive results. 2. The mechanism of action is different from the upcoming Pfizer pill, so it’s reasonable to expect they can be taken together as a cocktail for even better outcomes. 3. It is showing positive results with other viruses in animals.
Cool stuff!
- elliekelly 5y ago> The Ridgeback founders were on CNBC this morning in a very encouraging interview. This just feels wrong and makes me uncomfortable for reasons I’m not quite able to articulate.
- tiahura 5y agoWhy? It’s my understanding that this flows from work done years ago at Emory University. With the exciting news, why shouldn’t they take a bit of a victory lap? Good for them.